Moderna has accused the FDA of moving the goal posts and being inconsistent with earlier advice. The FDA has refused to accept Moderna's marketing application of an mRNA-based seasonal influenza ...
Coding is not the only area where Opus 4.7 performs better than the company’s earlier models. According to Anthropic, it’s ...
Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results